In vivo imaging of region and cell type specific neocortical neurodegeneration in Alzheimer's disease
暂无分享,去创建一个
G. E. Alexander | H. Möller | G. Alexander | S. Rapoport | H. Hampel | S. Teipel | O. Pogarell | H. Hampel | H.-J. Möller | S. I. Rapoport | S. J. Teipel | O. Pogarell | Harald Hampel | Oliver Pogarell | Stefan J. Teipel | Gene E. Alexander
[1] Barry Horwitz,et al. Discriminant analysis of MRI measures as a method to determine the presence of dementia of the Alzheimer type , 1995, Psychiatry Research.
[2] H. Soininen,et al. Volumes of the Entorhinal and Perirhinal Cortices in Alzheimer’s Disease , 1998, Neurobiology of Aging.
[3] M N Rossor,et al. Patterns of temporal lobe atrophy in semantic dementia and Alzheimer's disease , 2001, Annals of neurology.
[4] Stanley I. Rapoport,et al. In vivo PET imaging and postmortem studies suggest potentially reversible and irreversible stages of brain metabolic failure in Alzheimer’s disease , 1999, European Archives of Psychiatry and Clinical Neuroscience.
[5] D. Pandya,et al. The topographical distribution of interhemispheric projections in the corpus callosum of the rhesus monkey. , 1971, Brain research.
[6] H. Gertz,et al. Cortical distribution of neurofibrillary tangles in Alzheimer's disease matches the pattern of neurons that retain their capacity of plastic remodelling in the adult brain , 1998, Neuroscience.
[7] Gene E. Alexander,et al. Volumes of Medial Temporal Lobe Structures in Patients with Alzheimer’s Disease and Mild Cognitive Impairment (and in Healthy Controls) , 1998, Biological Psychiatry.
[8] C. Jack,et al. Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease , 1997, Neurology.
[9] Callosal atrophy and associated electromyographic responses in Alzheimer's disease and aging. , 2000, Electromyography and clinical neurophysiology.
[10] B Horwitz,et al. Corpus callosum atrophy is a possible indicator of region- and cell type-specific neuronal degeneration in Alzheimer disease: a magnetic resonance imaging analysis. , 1998, Archives of neurology.
[11] M. Mesulam. Cholinesterases in Alzheimer’s Disease , 1995 .
[12] J. Haxby,et al. Network analysis of brain cognitive function using metabolic and blood flow data , 1995, Behavioural Brain Research.
[13] J. Trojanowski,et al. The cells of origin of the corpus callosum in rat, cat and rhesus monkey. , 1974, Brain research.
[14] Callosal atrophy and associated electromyographic responses in Alzheimer's disease and aging. , 2000 .
[15] C. Grady,et al. Intercorrelations of regional cerebral glucose metabolic rates in Alzheimer's disease , 1987, Brain Research.
[16] G. Frisoni,et al. Hippocampal and entorhinal cortex atrophy in frontotemporal dementia and Alzheimer’s disease , 1999, Neurology.
[17] G. Alexander,et al. The neurometabolic landscape of cognitive decline: in vivo studies with positron emission tomography in Alzheimer's disease. , 2000, International journal of psychophysiology : official journal of the International Organization of Psychophysiology.
[18] P Pietrini,et al. Corpus Callosum Measurement as an in Vivo Indicator for Neocortical Neuronal Integrity, but not White Matter Pathology, in Alzheimer's Disease , 2000, Annals of the New York Academy of Sciences.
[19] C. Grady,et al. Heterogeneous anterior‐posterior metabolic patterns in dementia of the Alzheimer type , 1988, Neurology.
[20] J. Mazziotta,et al. [18F]-fluorodeoxyglucose (FDG) and positron emission tomography (PET) in aging and dementia. A decade of studies. , 1989, European neurology.
[21] Terry L. Jernigan,et al. Cerebral structure on MRI, part II: Specific changes in Alzheimer's and Huntington's diseases , 1991, Biological Psychiatry.
[22] A. Alavi,et al. Quantitative analysis of PET and MRI data in normal aging and Alzheimer's disease: atrophy weighted total brain metabolism and absolute whole brain metabolism as reliable discriminators. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[23] J V Haxby,et al. High-resolution PET studies in Alzheimer's disease. , 1991, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.
[24] Giorgio M. Innocenti,et al. Cellular aspects of callosal connections and their development , 1995, Neuropsychologia.
[25] S Lehéricy,et al. Amygdalohippocampal MR volume measurements in the early stages of Alzheimer disease. , 1994, AJNR. American journal of neuroradiology.
[26] Patrick Vermersch,et al. White matter magnetic resonance imaging hyperintensity in Alzheimer's disease: correlations with corpus callosum atrophy , 1996, Journal of Neurology.
[27] A. Convit,et al. Specific Hippocampal Volume Reductions in Individuals at Risk for Alzheimer’s Disease , 1997, Neurobiology of Aging.
[28] Nick C Fox,et al. Imaging of onset and progression of Alzheimer's disease with voxel-compression mapping of serial magnetic resonance images , 2001, The Lancet.
[29] Robert P. Friedland,et al. Alzheimer's disease: Anterior-posterior and lateral hemispheric alterations in cortical glucose utilization , 1985, Neuroscience Letters.
[30] Hirofumi Sakurai,et al. Diffusion-weighted and magnetization transfer imaging of the corpus callosum in Alzheimer’s disease , 1999, Journal of the Neurological Sciences.
[31] M. Albert,et al. Temporal lobe regions on magnetic resonance imaging identify patients with early Alzheimer's disease. , 1993, Archives of neurology.
[32] S. Sunderland. THE DISTRIBUTION OF COMMISSURAL FIBRES IN THE CORPUS CALLOSUM IN THE MACAQUE MONKEY , 1940, Journal of neurology and psychiatry.
[33] J Bohl,et al. Staging of Alzheimer-Related Cortical Destruction , 1997, International Psychogeriatrics.
[34] C. Grady,et al. Cerebral Metabolism in Aging and Dementia , 1992 .
[35] C. Jack,et al. Usefulness of MRI measures of entorhinal cortex versus hippocampus in AD , 2000, Neurology.
[36] J. Haxby,et al. Relations between Neuropsychological and Cerebral Metabolic Asymmetries in Early Alzheimer's Disease , 1985, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[37] Hidenao Fukuyama,et al. Comparison of the pattern of atrophy of the corpus callosum in frontotemporal dementia, progressive supranuclear palsy, and Alzheimer's disease , 2000, Journal of neurology, neurosurgery, and psychiatry.
[38] D P Salmon,et al. Regional cerebral volume loss associated with verbal learning and memory in dementia of the Alzheimer type. , 1999, Neuropsychology.
[39] S. DeKosky,et al. Structural correlates of cognition in dementia: quantification and assessment of synapse change. , 1996, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.
[40] Z. Wang,et al. Localization of functional projections from corpus callosum to cerebral cortex. , 1991, Chinese medical journal.
[41] Ruth A. Carper,et al. Atrophy of the Corpus Callosum in Alzheimer's Disease Versus Healthy Aging , 1996, Journal of the American Geriatrics Society.
[42] C. Cuénod,et al. Amygdala atrophy in Alzheimer's disease. An in vivo magnetic resonance imaging study. , 1993, Archives of neurology.
[43] S. Rapoport,et al. Positron emission tomography in Alzheimer's disease in relation to disease pathogenesis: a critical review. , 1991, Cerebrovascular and brain metabolism reviews.
[44] P Pietrini,et al. Region-specific corpus callosum atrophy correlates with the regional pattern of cortical glucose metabolism in Alzheimer disease. , 1999, Archives of neurology.
[45] Harald Hampel,et al. Age transformation of combined hippocampus and amygdala volume improves diagnostic accuracy in Alzheimer's disease , 2002, Journal of the Neurological Sciences.
[46] H. Fukuyama,et al. Callosal atrophy parallels decreased cortical oxygen metabolism and neuropsychological impairment in Alzheimer's disease. , 1993, Archives of neurology.
[47] L. Schad,et al. Corpus callosum in Alzheimer's disease and vascular dementia--a quantitative magnetic resonance study. , 1998, Journal of neural transmission. Supplementum.
[48] D. Bennett,et al. From Healthy Aging to Early Alzheimer's Disease: In Vivo Detection of Entorhinal Cortex Atrophy , 2000, Annals of the New York Academy of Sciences.
[49] C. Jack,et al. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment , 1999, Neurology.
[50] F. Conti,et al. The neurotransmitters and postsynaptic actions of callosally projecting neurons , 1994, Behavioural Brain Research.
[51] J. Baron,et al. In Vivo Mapping of Gray Matter Loss with Voxel-Based Morphometry in Mild Alzheimer's Disease , 2001, NeuroImage.
[52] J. Haxby,et al. Positron emission tomography in Alzheimer's disease , 1986, Neurology.
[53] A. Smith,et al. Hippocampal pathology reflects memory deficit and brain imaging measurements in Alzheimer's disease: clinicopathologic correlations using three sets of pathologic diagnostic criteria. , 1996, Dementia.
[54] J V Haxby,et al. Network analysis of PET-mapped visual pathways in Alzheimer type dementia. , 1995, Neuroreport.
[55] J. Haxby,et al. Longitudinal study of cerebral metabolic asymmetries and associated neuropsychological patterns in early dementia of the Alzheimer type. , 1990, Archives of neurology.
[56] E. Ross,et al. Topography of the Human Corpus Callosum , 1985, Journal of neuropathology and experimental neurology.
[57] G. Innocenti. General Organization of Callosal Connections in the Cerebral Cortex , 1986 .
[58] H. Soininen,et al. Comparative MR analysis of the entorhinal cortex and hippocampus in diagnosing Alzheimer disease. , 1999, AJNR. American journal of neuroradiology.
[59] B. Hyman,et al. Neuroanatomy of Alzheimer's disease: Hierarchical vulnerability and neural system compromise , 1995, Neurobiology of Aging.
[60] H. Möller,et al. PET in alzheimer's disease--From resting-state to activation studies , 1999 .
[61] B. Horwitz,et al. Volumetric magnetic resonance imaging in men with dementia of the Alzheimer type: Correlations with disease severity , 1993, Biological Psychiatry.
[62] O Nalcioglu,et al. Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer's disease , 1991, Neurology.
[63] In Kyoon Lyoo,et al. Regional atrophy of the corpus callosum in subjects with Alzheimer's disease and multi-infarct dementia , 1997, Psychiatry Research: Neuroimaging.
[64] G D Pearlson,et al. Quantitative changes in mesial temporal volume, regional cerebral blood flow, and cognition in Alzheimer's disease. , 1992, Archives of general psychiatry.
[65] B. C. Richardson,et al. Human corpus callosum in aging and alzheimer's disease: a magnetic resonance imaging study , 1994, Neurobiology of Aging.
[66] W. Jagust,et al. Quantitative NMR measurements of hippocampal atrophy in Alzheimer's disease , 1988, Magnetic resonance in medicine.
[67] F. O. Schmitt,et al. The Organization of the Cerebral Cortex. , 1982 .
[68] Hiroaki Kazui,et al. Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease: a comparative study using positron emission tomography , 1997, Neuroscience Letters.
[69] K. Baudendistel,et al. In vivo Quantification of Brain Volumes in Subcortical Vascular Dementia and Alzheimer’s Disease , 1998, Dementia and Geriatric Cognitive Disorders.
[70] D. Benson,et al. The fluorodeoxyglucose 18F scan in Alzheimer's disease and multi-infarct dementia. , 1983, Archives of neurology.
[71] Harald Hampel,et al. Progression of corpus callosum atrophy in Alzheimer disease. , 2002, Archives of neurology.
[72] D. Whitteridge,et al. Degeneration of layer III pyramidal cells in area 18 following destruction of callosal input , 1976, Brain Research.
[73] A. Convit,et al. Hippocampal formation glucose metabolism and volume losses in MCI and AD , 2001, Neurobiology of Aging.
[74] R. Woods,et al. Cortical change in Alzheimer's disease detected with a disease-specific population-based brain atlas. , 2001, Cerebral cortex.
[75] C. Grady,et al. Parametric in vivo brain imaging during activation to examine pathological mechanisms of functional failure in Alzheimer disease. , 1993, The International journal of neuroscience.
[76] T. Arendt. Alzheimer’s disease as a loss of differentiation control in a subset of neurons that retain immature features in the adult brain , 2000, Neurobiology of Aging.
[77] Toshio Mizutani,et al. Hippocampal atrophy secondary to entorhinal cortical degeneration in Alzheimer-type dementia , 1997, Neuroscience Letters.
[78] G K Wilcock,et al. Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer disease. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[79] A. Alavi,et al. Analysis of brain and cerebrospinal fluid volumes with MR imaging: impact on PET data correction for atrophy. Part II. Aging and Alzheimer dementia. , 1991, Radiology.